Travere Therapeutics Inc (NASDAQ:TVTX)

19.50
Delayed Data
As of Nov 25
 +0.17 / +0.88%
Today’s Change
18.92
Today|||52-Week Range
31.65
-37.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.2B

Company Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Contact Information

Travere Therapeutics, Inc.
3611 Valley Centre Drive
San Diego California 92130
P:(888) 969-7879
Investor Relations:

Employees

Shareholders

Other institutional73.40%
Mutual fund holders35.52%
Individual stakeholders1.32%

Top Executives

Eric M. DubePresident, Chief Executive Officer & Director
Chris ClineChief Financial Officer
Bill RoteSenior VP, Head-Research & Development
Jula InrigChief Medical Officer
Elizabeth E. ReedSecretary, Senior Vice President & General Counsel